tiprankstipranks
Champions Oncology Inc (CSBR)
NASDAQ:CSBR
US Market
CSBR
Champions Oncology
RESEARCH TOOLSreports
Want to see CSBR full AI Analyst Report?

Champions Oncology (CSBR) Ratios

141 Followers

Champions Oncology Ratios

CSBR's free cash flow for Q3 2026 was $0.45. For the 2026 fiscal year, CSBR's free cash flow was decreased by $ and operating cash flow was $-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Apr 25Apr 24Apr 23Apr 22
Liquidity Ratios
Current Ratio
 0.98 0.94 0.63 0.90 1.13
Quick Ratio
 0.98 0.94 0.63 0.90 1.13
Cash Ratio
 0.34 0.41 0.12 0.47 0.52
Solvency Ratio
 -0.03 0.22 -0.19 -0.07 0.11
Operating Cash Flow Ratio
 0.21 0.31 -0.28 0.18 0.37
Short-Term Operating Cash Flow Coverage
 2.73 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -3.88M$ -6.20M$ -14.40M$ -10.22M$ -6.62M
Leverage Ratios
Debt-to-Assets Ratio
 0.18 0.19 0.28 0.25 0.27
Debt-to-Equity Ratio
 1.17 1.62 -3.90 1.85 1.04
Debt-to-Capital Ratio
 0.54 0.62 1.34 0.65 0.51
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 6.64 8.57 -13.73 7.40 3.89
Debt Service Coverage Ratio
 -0.52 235.85 -192.18 0.00 123.38
Interest Coverage Ratio
 0.00 179.48 -247.18 0.00 25.29
Debt to Market Cap
 0.02 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.36 0.45 0.55 0.64 0.72
Net Debt to EBITDA
 2.37 -0.58 -0.89 0.73 0.15
Profitability Margins
Gross Profit Margin
43.37%47.27%41.38%45.18%51.88%
EBIT Margin
-4.05%8.17%-14.52%-9.78%1.19%
EBITDA Margin
-1.55%11.05%-10.79%-3.84%6.10%
Operating Profit Margin
-3.84%8.51%-13.80%-8.26%1.24%
Pretax Profit Margin
-4.14%8.12%-14.57%-9.78%1.19%
Net Profit Margin
-3.88%8.26%-14.51%-9.90%1.12%
Continuous Operations Profit Margin
-4.04%8.26%-14.51%-9.90%1.12%
Net Income Per EBT
93.83%101.62%99.56%101.29%94.00%
EBT Per EBIT
107.87%95.46%105.59%118.39%96.05%
Return on Assets (ROA)
-7.91%14.53%-27.84%-15.55%1.55%
Return on Equity (ROE)
-57.20%124.63%382.34%-115.08%6.02%
Return on Capital Employed (ROCE)
-28.61%57.07%-150.75%-35.37%3.39%
Return on Invested Capital (ROIC)
-23.16%48.64%-116.24%-32.27%3.01%
Return on Tangible Assets
-8.00%14.69%-28.20%-15.70%1.56%
Earnings Yield
-2.76%4.81%-11.07%-8.11%0.54%
Efficiency Ratios
Receivables Turnover
 4.80 5.07 5.27 6.72 5.16
Payables Turnover
 5.73 7.07 5.07 5.54 8.24
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 6.26 6.02 4.19 3.71 3.20
Asset Turnover
 2.04 1.76 1.92 1.57 1.39
Working Capital Turnover Ratio
 -89.08 -12.13 -9.86 -1.18K 27.16
Cash Conversion Cycle
 12.32 20.37 -2.68 -11.65 26.41
Days of Sales Outstanding
 76.01 72.01 69.32 54.28 70.70
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 63.70 51.63 72.00 65.93 44.30
Operating Cycle
 76.01 72.01 69.32 54.28 70.70
Cash Flow Ratios
Operating Cash Flow Per Share
 0.32 0.54 -0.45 0.29 0.49
Free Cash Flow Per Share
 0.27 0.51 -0.51 0.08 0.31
CapEx Per Share
 0.04 0.03 0.06 0.21 0.18
Free Cash Flow to Operating Cash Flow
 0.87 0.95 1.14 0.27 0.63
Dividend Paid and CapEx Coverage Ratio
 7.60 18.99 -7.34 1.38 2.73
Capital Expenditure Coverage Ratio
 7.60 18.99 -7.34 1.38 2.73
Operating Cash Flow Coverage Ratio
 0.88 1.21 -0.83 0.46 0.69
Operating Cash Flow to Sales Ratio
 0.08 0.13 -0.12 0.07 0.13
Free Cash Flow Yield
4.69%7.16%-10.61%1.65%4.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -36.20 20.78 -9.03 -12.34 184.95
Price-to-Sales (P/S) Ratio
 1.41 1.72 1.31 1.22 2.06
Price-to-Book (P/B) Ratio
 19.02 25.89 -34.53 14.20 11.14
Price-to-Free Cash Flow (P/FCF) Ratio
 21.34 13.96 -9.42 60.77 24.64
Price-to-Operating Cash Flow Ratio
 18.54 13.22 -10.71 16.64 15.60
Price-to-Earnings Growth (PEG) Ratio
 0.27 -0.13 -0.23 0.01 3.67
Price-to-Fair Value
 19.02 25.89 -34.53 14.20 11.14
Enterprise Value Multiple
 -88.33 14.94 -13.03 -31.07 33.98
Enterprise Value
 79.32M 93.99M 70.52M 64.29M 101.81M
EV to EBITDA
 -88.33 14.94 -13.03 -31.07 33.98
EV to Sales
 1.37 1.65 1.41 1.19 2.07
EV to Free Cash Flow
 20.79 13.43 -10.11 59.37 24.75
EV to Operating Cash Flow
 18.05 12.73 -11.49 16.26 15.67
Tangible Book Value Per Share
 0.29 0.25 -0.17 0.32 0.66
Shareholders’ Equity Per Share
 0.31 0.28 -0.14 0.34 0.69
Tax and Other Ratios
Effective Tax Rate
 0.02 -0.02 <0.01 -0.01 0.06
Revenue Per Share
 4.17 4.17 3.70 3.98 3.72
Net Income Per Share
 -0.16 0.34 -0.54 -0.39 0.04
Tax Burden
 0.94 1.02 1.00 1.01 0.94
Interest Burden
 1.02 0.99 1.00 1.00 1.00
Research & Development to Revenue
 0.15 0.12 0.19 0.21 0.19
SG&A to Revenue
 0.33 0.27 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.02 0.01 0.02 0.02 0.02
Income Quality
 -1.88 1.57 0.84 -0.74 11.86
Currency in USD